SCHEMBL21701591

SCHEMBL21701591

O=C(Nc1ccc(N2CCN(c3ncccn3)CC2)cc1C(=O)O)c1ccco1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ ALDH1A1 P00352 4/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ MAPK1 P28482 3/20 0.50
▸ CYP1A2 P05177 2/20 0.48
▸ ALOX15 P16050 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ GAA P10253 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ TSHR P16473 2/20 0.48
▸ MAPT P10636 4/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ LMNA P02545 1/20 0.46
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ HTT P42858 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701579 0.97 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HSD17B10MAPK1CYP1A2
SCHEMBL21683001 0.89 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1HSD17B10MAPK1CYP1A2
SCHEMBL21701587 0.86 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HSD17B10MAPK1CYP1A2
SCHEMBL21701474 0.84 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HSD17B10MAPK1CYP1A2
SCHEMBL21701605 0.78 MAPT (0.57) MAPTNPC1RAB9AKMT2A
SCHEMBL21701494 0.75 F10 (0.59) ALDH1A1MAPTRAB9AKMT2A
SCHEMBL21701478 0.72 CYP1A2 (0.61) SMN1; SMN2ALDH1A1HSD17B10MAPK1CYP1A2
SCHEMBL6815137 0.72 GFER (0.71) SMN1; SMN2ALDH1A1MAPK1CYP1A2KDM4E
SCHEMBL14075179 0.72 LTC4S (0.66) SMN1; SMN2MAPK1CYP1A2KDM4EGAA
SCHEMBL7657891 0.72 KDM4E (0.60) SMN1; SMN2ALDH1A1HSD17B10KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033944-A2 NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2020-02-13 — — WO disclosed
Send feedback